Sequence analysis

Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development

Retrieved on: 
星期三, 三月 27, 2024
Sequence, Sequence analysis, Automation, Quality control, Logic, Database, Algorithm, Communication, Intelligence, Printing, Biomedical Research, Digitalization, Sequence alignment, Acceleration, Internet, Research, ELISA, Artificial intelligence, Software, PTM, Record, Molecular biology, CDE, Thought, Hook effect, Investment, Drug development, Telephone numbers in Hungary, Literature, Digital technology, EC50, Collection, Data management, Marketing, FDA, Parallel, Map, Mobile phone

This is the driving force behind Sanyou's development of an intelligence-enabled innovative biologics R&D platform.

Key Points: 
  • This is the driving force behind Sanyou's development of an intelligence-enabled innovative biologics R&D platform.
  • This system finds extensive applications across various domains, including research and development, data management, project management, quality control, and marketing.
  • By optimizing drug development processes and supporting intelligence-enabled decision-making, it comprehensively enhances R&D efficiency and accuracy, potentially playing a critical role in drug development.
  • In drug development, the modeling and prediction of drug developability analysis aims to comprehensively enhance the efficiency of the drug development process.

Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform

Retrieved on: 
星期三, 三月 13, 2024
Sequence analysis, Automation, Computational biology, Communication, Drug discovery, Research, AI, Intelligence, Statistics, Drug development, Fine chemical

SHANGHAI, March 12, 2024 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," representing a transformative advancement in biopharmaceutical research and development.

Key Points: 
  • SHANGHAI, March 12, 2024 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," representing a transformative advancement in biopharmaceutical research and development.
  • Additionally, advanced capabilities for sequence analysis, primer design, experimental data processing, and drug development are integrated into the platform.
  • By merging bioinformatics, computational science, statistics, automation technology, and drug screening technology, we have created an Intelligent R&D platform tailored for innovative biopharmaceuticals.
  • The launch of our "Sanyou Intelligent Innovative Biologics R&D Service Platform" will greatly enhance delivery efficiency, quality, and speed, improving communication and accelerating innovative biopharmaceutical research and development."

Process Mining Markets by Software, Services, Mining Algorithm, Data Source, Vertical and Region - Global Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
星期二, 一月 23, 2024
Security, Robotics, Technology, Artificial Intelligence, Software, Sequence, ERP, Privacy, Data source, Mining, Deep learning, Sequence analysis, Customer, Region, Enterprise, Growth

The "Process Mining Market by Offering (Software (Process Discovery Tools, Conformance Checking Tools), Services), Mining Algorithm (Deep Learning, Sequence Analysis), Data Source (ERP Systems, CRM Systems), Vertical and Region - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Process Mining Market by Offering (Software (Process Discovery Tools, Conformance Checking Tools), Services), Mining Algorithm (Deep Learning, Sequence Analysis), Data Source (ERP Systems, CRM Systems), Vertical and Region - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • This robust growth is primarily fueled by the necessity for specialized expertise and tailored solutions within the process mining domain.
  • ERP systems are comprehensive platforms that consolidate diverse business processes, making them a primary data source for process mining.
  • In terms of regional growth, North America is poised to attain the highest growth rate in the process mining market.

Global Process Mining Market Research Report 2023-2028: Opportunities in Artificial Intelligence and Machine Learning Integration and Rising Demand for Cloud-Based Solutions

Retrieved on: 
星期二, 一月 23, 2024
Sequence, ERP, Privacy, Data source, Mining, Deep learning, Software, Sequence analysis, Customer, Region, Enterprise, Growth

Within this market, the services segment is expected to achieve the fastest market growth rate throughout the forecast period.

Key Points: 
  • Within this market, the services segment is expected to achieve the fastest market growth rate throughout the forecast period.
  • This robust growth is primarily fueled by the necessity for specialized expertise and tailored solutions within the process mining domain.
  • In terms of regional growth, North America is poised to attain the highest growth rate in the process mining market.
  • On the other hand, Europe is set to dominate the regional segment of the process mining market, boasting the largest market share.

Benchling Delivers an Integrated R&D Ecosystem with New Product Offerings

Retrieved on: 
星期二, 六月 6, 2023
Cloud, Product management, GitHub, Registry, Table, API, JSL, ASM, BLAST, Research, RNA, McKinsey & Company, Science, GATC Biotech, Molecular biology, Protein, JMP, Collection, Data, Algorithm, RNA therapeutics, Sequence analysis, Digital, R, Therapy, Environment, AlphaFold, FAIR, Fine chemical, Pluto, Notebook

SAN FRANCISCO, June 6, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry, today launched new integrations and features that connect data and analytics tools directly in Benchling with just a few clicks, providing scientists with a connected platform to make faster decisions and generate better insights. Scientists now have out-of-the-box integrations to leading scientific analytics tools like JMP as well as Pluto and Watershed. This delivers effortless push and pull of data, results, and charts between Benchling and these solutions, along with API endpoints for developers to build their own analytics integrations. In addition, scientists can now use the latest, powerful sequence analysis algorithms BLAST (Basic Local Alignment Search Tool) and AlphaFold for protein and DNA/RNA sequence design and analysis within Benchling's comprehensive RNA Therapeutics and Molecular Biology products. To simplify instrument data capture and analysis, Benchling also announced an open source library of instrument data converters that automatically format instrument-generated data to the Allotrope Simple Model (ASM) standard, available this July.

Key Points: 
  • Scientists now have out-of-the-box integrations to leading scientific analytics tools like JMP as well as Pluto and Watershed.
  • This delivers effortless push and pull of data, results, and charts between Benchling and these solutions, along with API endpoints for developers to build their own analytics integrations.
  • Scientists that rely on both Benchling and JMP every day to manage their R&D can now make their work that much more easy, convenient, and integrated," said Daniel Valente , Director of Product Management, JMP.
  • We're delivering on a connected lab today with our latest launch at Benchling," said Shawna Wolverton, Chief Product Officer, Benchling.

PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes

Retrieved on: 
星期二, 三月 14, 2023
SVS, Sequence analysis, CNV, SMN1, SMA, STRC, SNV calling from NGS data, Genome, Deafness, High fidelity, SMN2, Huber loss, Gene, Genetics, Associate, Radboud University Medical Center, Ehlers–Danlos syndromes, Abraxis BioScience, Pseudogene, Computational biology, Allele, TNXB, Haplotype, Antibiotics

MENLO PARK, Calif., March 14, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a new informatics method that genotypes gene paralogs and pseudogenes with high accuracy. The new computational tool, named "Paraphase," enables variant calling, copy number analysis and phasing by identifying the full gene sequence of each of the haplotypes for all genes and pseudogenes of the same gene family. Many medically relevant genes fall into segmental duplications and thus have highly similar gene family members or pseudogenes. The sequence similarity often leads to error prone read alignment and variant calling.

Key Points: 
  • MENLO PARK, Calif., March 14, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a new informatics method that genotypes gene paralogs and pseudogenes with high accuracy.
  • Many medically relevant genes fall into segmental duplications and thus have highly similar gene family members or pseudogenes.
  • SMN1 is >99.9 percent similar in sequence to its paralog, SMN2, and both genes have variable copy numbers across populations.
  • Paraphase is being extended into a genome-wide generalized paralog caller as more highly homologous genes are included.

Global Long Read Sequencing Market Report to 2031 - Featuring Agilent Technologies, BaseClear, Cantata Bio and F. Hoffmann-La Roche Among Others

Retrieved on: 
星期二, 一月 10, 2023
Cancer, Agilent Technologies, Nanopore, SMRT, Comprehension, Research, Nanopore sequencing, DNA, Application, Genomics, Porter's five forces analysis, Growth, Genome, Benchmarking, Cloud computing, Oxford Nanopore Technologies, Clifton Springs Hospital & Clinic, Illumina, Inc., Investment, Drug resistance, Hospital, Conditional sentence, Sequence analysis, Data management, Prevalence, Book

Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program.

Key Points: 
  • Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2021 to 2031 to identify the prevailing long read sequencing market opportunities.
  • In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.
  • The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.

Insights on the Long Read Sequencing Global Market to 2031 - Rise in Utilization of Sequence Analysis Methodologies Drives Growth - ResearchAndMarkets.com

Retrieved on: 
星期五, 一月 6, 2023
Health, Genetics, Cancer, Nanopore, Comprehension, DNA, Application, Genomics, Porter's five forces analysis, Growth, Genome, Benchmarking, Cloud computing, Investment, Drug resistance, Conditional sentence, Sequence analysis, Data management, Prevalence, Book

Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program.

Key Points: 
  • Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2021 to 2031 to identify the prevailing long read sequencing market opportunities.
  • In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.
  • The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.

Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

Retrieved on: 
星期二, 九月 21, 2021
Diamond, Sequence analysis, Cancer, M26 Modular Accessory Shotgun System, Partnership, OpenEye Scientific Software, Annual report, Private Securities Litigation Reform Act, Black Diamond, Economics, Patient, U.S. Securities and Exchange Commission, CEO, Industry, Genomics, Company, Entrepreneurship, MAP, Founder, COVID-19, Marriage, Technology, IND, Drug discovery, Doctor of Philosophy, Agrochemical, Orion, Amazon Web Services, Protein, GLOBE, Pharmaceutical industry, Risk management, Medical imaging

CAMBRIDGE, Mass. and SANTA FE, N.M., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, and OpenEye Scientific, a leader in computational molecular design, today announced that they are entering into a strategic partnership incorporating OpenEye’s Orion® molecular design platform into Black Diamond’s proprietary Mutation-Allostery-Pharmacology (MAP) drug discovery engine to advance Black Diamond’s efforts to develop MasterKey inhibitor cancer therapies.

Key Points: 
  • Black Diamond and OpenEye will collaborate to co-develop enhanced-sampling capabilities designed to deliver information on an accelerated time scale.
  • The deployment of these large-scale perturbations provides Black Diamond with detailed structural and dynamic information on target proteins to guide drug discovery efforts.
  • The arrangement between OpenEye and Black Diamond involves an upfront payment and potential downstream economics resulting from select Black Diamond products for OpenEye.
  • Were very proud to be able to work with Black Diamond to combine molecular simulation on our cloud platform, Orion, with their MAP drug discovery engine to accelerate their search for novel cancer therapeutics.

Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

Retrieved on: 
星期二, 九月 21, 2021
Diamond, Sequence analysis, Cancer, M26 Modular Accessory Shotgun System, Partnership, Black Diamond Coal Mining Company, OpenEye Scientific Software, Annual report, Economics, Private Securities Litigation Reform Act, Black Diamond, Patient, U.S. Securities and Exchange Commission, CEO, Industry, Genomics, Company, Entrepreneurship, MAP, Founder, COVID-19, Marriage, Technology, IND, Drug discovery, Doctor of Philosophy, Agrochemical, Amazon Web Services, Protein, Pharmaceutical industry, Medical imaging

Black Diamond and OpenEye will collaborate to co-develop enhanced-sampling capabilities designed to deliver information on an accelerated time scale.

Key Points: 
  • Black Diamond and OpenEye will collaborate to co-develop enhanced-sampling capabilities designed to deliver information on an accelerated time scale.
  • The arrangement between OpenEye and Black Diamond involves upfront payment and potential downstream economics resulting from select Black Diamond products for OpenEye.
  • We're very proud to be able to work with Black Diamond to combine molecular simulation on our cloud platform, Orion, with their MAP drug discovery engine to accelerate their search for novel cancer therapeutics."
  • Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, MasterKey therapies.